Delivery Order SPE2DB20D3103-SPE2DB23FN1H8
Award Date 4/19/23
Potential Completion Date 4/20/23
Potential Value $5.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a ceiling value of $1,872.03 and a period of performance through June 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corporation holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medication, with a ceiling value of $1,461.05 and a period of performance through April 17, 2025. This award is not a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of BARHEMSYS 10 mg/4 ml vials with a ceiling value of $1,285.79. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $4,813.91 to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 mL vials on January 21, 2026, with completion scheduled for January 22, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,169.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Barhemsys 5 mg/2 ml vial (2 ml units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense...
- The Defense Logistics Agency issued a $2,329.16 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for Barhemsys 5 mg/2 ml vial pharmaceutical supply. This is a call against the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed-price pricing with an...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for barhemsys 10 mg/4 ml vial (4 ml) with a firm fixed price ceiling of $1,191.16. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 1, 2026. No set-aside was used. The order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00...
- The Defense Logistics Agency issued a $19,114.71 delivery order to Amerisourcebergen Drug Corp on January 26, 2026, for barhemsys 10 mg/4 ml vial pharmaceutical supply. The order is issued under the DLA Troop Support Medical indefinite delivery contract SPE2DX, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure and an ultimate completion date of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $78,975.43 and runs through June 11, 2024. The contract is for a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to...
- This is a $16,593 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and will run through April 2025. It is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies...